Free Trial
NASDAQ:ASPI

ASP Isotopes Q3 2023 Earnings Report

ASP Isotopes logo
$9.86 +0.73 (+8.00%)
Closing price 09/19/2025 04:00 PM Eastern
Extended Trading
$10.03 +0.17 (+1.76%)
As of 09/19/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ASP Isotopes EPS Results

Actual EPS
-$0.13
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

ASP Isotopes Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

ASP Isotopes Announcement Details

Quarter
Q3 2023
Time
N/A
Conference Call Date
Tuesday, November 14, 2023
Conference Call Time
7:00AM ET

Upcoming Earnings

ASP Isotopes' Q3 2025 earnings is scheduled for Thursday, November 13, 2025, with a conference call scheduled on Tuesday, November 18, 2025 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Earnings Documents

ASP Isotopes Earnings Headlines

Canaccord Genuity Group Reiterates Buy Rating for ASP Isotopes (NASDAQ:ASPI)
College grad makes $64,000 a month
A Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took dozens of technology and finance experts, including one PhD astrophysicist, and $4 million in total research costs). In a multi-year backtest, this breakthrough beat stocks, bonds, gold... even Warren Buffett.tc pixel
ASP Isotopes Extends Deadline for Renergen Acquisition
ASP Isotopes Expands Board with New Appointment
See More ASP Isotopes Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ASP Isotopes? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ASP Isotopes and other key companies, straight to your email.

About ASP Isotopes

ASP Isotopes (NASDAQ:ASPI), a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.

View ASP Isotopes Profile

More Earnings Resources from MarketBeat